Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

87
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
87
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

141
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
141
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

130
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
130
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

117
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
117
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

63
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
63
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

115
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
115

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic and prognostic relevance of valve strands in patients with suspected infective endocarditis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Mind the Gap: Inadequate Performance of Embolic Risk Scores in Infective Endocarditis.

Open forum infectious diseases·2026
Same author

Recipient-Donor Sex Combinations and Posttransplant Infections: A Swiss Transplant Cohort Study.

Transplant infectious disease : an official journal of the Transplantation Society·2026
Same author

Linezolid in addition to standard antibiotic treatment for <i>Staphylococcus aureus</i> bacteraemia: study protocol for a randomised, placebo-controlled trial.

BMJ open·2026
Same author

Evaluation of the MEFIER Score in Identifying Patients at High Risk of Endocarditis in <i>Enterococcus faecalis</i> Bacteremia.

Open forum infectious diseases·2026
Same author

Resolution of long-term severe irritable bowel syndrome following fecal microbiota transplantation: A case report and microbiota analysis.

Gut microbes reports·2026
Same journal

Metamizole-induced agranulocytosis: utilisation trends, pharmacovigilance signals and regulatory risk-minimisation in Switzerland.

Swiss medical weekly·2026
Same journal

Female genital mutilation/cutting and risk of obstetric anal sphincter injury at delivery.

Swiss medical weekly·2026
Same journal

Drug prescription before and after implementation of a CPOE system on the Paediatric Intensive Care Unit: a quality improvement study.

Swiss medical weekly·2026
Same journal

Trends in health- and lifestyle-related aspects in women of childbearing age: analysis of Swiss Health Survey data between 1992 and 2022.

Swiss medical weekly·2026
Same journal

Microplastics in the air and potential health risks - a narrative review.

Swiss medical weekly·2026
Same journal

Potentially inappropriate medication: prevalence, risk of hospitalisation and associated healthcare costs in the general older population of Switzerland.

Swiss medical weekly·2026
See all related articles

Related Experiment Video

Updated: Nov 14, 2025

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

185

Infective endocarditis: prevention and antibiotic prophylaxis.

Parham Sendi1, Barbara Hasse2, Michelle Frank3

  • 13010 | SWITZERLAND.

Swiss Medical Weekly
|March 11, 2021
PubMed
Summary
This summary is machine-generated.

Updated guidelines emphasize comprehensive prevention for infective endocarditis. Antibiotic prophylaxis is now reserved for high-risk patients, with specific criteria and exclusions for certain conditions.

More Related Videos

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

7.1K
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

16.4K

Related Experiment Videos

Last Updated: Nov 14, 2025

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

185
An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

7.1K
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

16.4K

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Pediatric Cardiology

Background:

  • Infective endocarditis (IE) remains a significant concern, necessitating updated prevention strategies.
  • Previous recommendations for IE prophylaxis required review based on evolving evidence and clinical practice.

Purpose of the Study:

  • To present revised recommendations for infective endocarditis prophylaxis in Switzerland.
  • To outline a comprehensive prevention campaign targeting at-risk patient populations.
  • To clarify indications for antibiotic prophylaxis in dental and non-dental interventions.

Main Methods:

  • Joint initiative by Swiss societies of Infectious Diseases, Pediatric Cardiology, Cardiology, and the Pediatric Infectious Disease Group.
  • Review and revision of existing guidelines for infective endocarditis prophylaxis.
  • Categorization of recommendations for antibiotic prophylaxis based on risk stratification and intervention type.

Main Results:

  • Focus shifted to a comprehensive prevention campaign for all at-risk patients.
  • Antibiotic prophylaxis is now recommended exclusively for individuals identified as high-risk.
  • Specific high-risk criteria are detailed, with a defined ranking order.
  • Antibiotic prophylaxis is no longer advised for patients with unrepaired ventricular septal defects and patent ductus arteriosus.

Conclusions:

  • Revised guidelines prioritize targeted antibiotic prophylaxis for high-risk individuals to prevent infective endocarditis.
  • The updated recommendations aim to optimize prevention strategies and reduce unnecessary antibiotic use.
  • Clear guidance is provided for antibiotic prophylaxis related to both dental and non-dental procedures.